Background
We assessed HIV RNA suppression, resistance, and CD4 T-cell count 12 months post-partum among pregnant women retained in care in an observational cohort study.
Methods
We prospectively followed two groups of HIV-infected pregnant women - with or without tuberculosis - recruited from pre-natal clinics in South Africa. Women who received antiretroviral therapy during pregnancy and reported being on therapy 12 months post-partum were included. Serum samples from women with HIV viremia 12 months post-partum were tested for drug resistance.
Results
Of 103 women in the study, median age and CD4 T-cell count at enrollment were 29 years [interquartile range (IQR): 26, 32] and 317 cells/mm3 (IQR: 218, 385), respectively; 43 (42%) had tuberculosis at baseline. During pregnancy, 87% of the women achieved an HIV RNA <400 c/mL compared to 71% at 12 months post-partum (p<0.001). Factors independently associated with an HIV RNA <400 c/mL at 12 months were age ≥30 years, detectable plasma efavirenz concentration, and HIV RNA <400 c/mL while pregnant; there was a trend toward both a detectable viral load and peripartum depression. HIV drug resistance results were available from 25 women, 12 (48%) had major drug resistance mutations. CD4 T-cell count declined a median of 13 cells/mm3 (IQR: -66, 140) from delivery to 12 months in women with viremia at 12 months
Conclusions
Success with maintaining virologic control declined post-partum among HIV-infected women who remained in care and on ART, and CD4 T-cell count decline and drug resistance was common.